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Aim
The aim of this study is to show that it is possible
to extract relevant information about molecular
imaging from published articles.
Introduction:
Databasing molecular neuroimaging
The Brede Database [1] is a database that so far
has recorded data from neuroimaging studies with
the stereotaxic “Talairach” coordinates [2]. Such
a representation allows for a variety of information
extraction methods [3, 4, 5]. These coordinates
will typically originate from cognitive neuroimag-
ing studies with positron emission tomography or
functional magnetic resonance imaging. Results
from molecular neuroimaging studies with single-
photon or positron emission tomography (PET)
such as receptor imaging data are often reported in
the form of values of interest across a set of brain
regions, with only a few molecular neuroimaging
studies using Talairach coordinates
We here report the first method for information ex-
traction across multiple published molecular neu-
roimaging studies:
We used K-means to cluster experiments based
on the normalized values of interest across brain
regions. Molecular neuroimaging studies was en-
tered in a database from published peer-reviewed
articles via the Brede Neuroinformatics Toolbox,
the brain regions were linked to an ontology, and
an experiments-by-brain-regions data matrix was
constructed. This matrix was subsequently ana-
lyzed with a hierarchical K-means algorithm.
Data: Brain region values
The example above is the graphical user interface
for data entry with information from one of the
four experiments reported in a dopamine receptor
study [6]. This study reports estimated binding
potentials across 11 brain regions with four differ-
ent analysis techniques.
The values that are entered are primarily neurore-
ceptor specific, such as binding potentials and dis-
tribution volumes for neuroligands. A few other
types of values were also entered, e.g., K1 rate
constants and distribution of compounds such as
vinpocetine.
To account for the variability in the values of in-
terest these values were normalized with “studen-
tization”, i.e., for each experiment the mean is
extracted and the centered values are normalized
with the standard deviation.
Brain anatomy ontology
The brain regions included will vary, e.g., some
studies only report values for cerebral cortex while
others include values for thalamus, putamen, cau-
date, pons, . . . The detail of the segmentation also
vary, e.g., with studies providing values from 4 to
21 regions [7, 8].
The segmentation used for the brain regions dif-
fers between studies. Typically the brain regions
are only referred to by name, e.g., “frontal cortex”,
and the exact delineation is not given. It is difficult
to know exactly what subregion the same designa-
tion refers to when used in different studies. We
have presently chosen to ignore this problem and
link the brain regions in the individual studies to
the “nearest” items in a taxonomy (a simple on-
tology).
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The diagram above shows part of the taxomony
for cingulate regions.
Only regions where more than two experiments
report values were included, but even then the
experiment-by-brain-region data matrix contains
many “wholes”, i.e., “missing values”.
Method: K-means clustering
K-means is a simple standard cluster analysis algo-
rithm where the intra-component variance is min-
imized, see, e.g., [9]:
Initialization
1. SelectK objects randomly and use
these as component centroids
Iterative scheme
1. Calculate distances between all ob-
jects and all centroids and reassign
the objects to the closest centroid.
2. Calculate the centroid for each
component using all of their as-
signed objects.
The K-means algorithm was modified to handle
“missing values” in the data matrix. The miss-
ing value K-means typically converges to unfavor-
able local minima and the algorithm is run multi-
ple times with different initialization assignments.
The run with the lowest intra-component variance
is selected.
The number of components in the clustering was
varied and a graphical technique was used to get
an overview of the components [10].
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Results: Hierarchical K-means clustering of experiments
We have presently extended the database of region-based molecular neuroimaging studies to 43
experiments contained in 18 articles. Combined they report values in 68 different brain regions, and
it results in a 43-by-68 matrix. After excluding regions where less than 3 experiments report values
the matrix is sized 43-by-30, i.e., excluding 38 regions.
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Results of the clustering of experiments appear above. The yellow circles each denotes a component
in the cluster analysis and their sizes indicate how many experiments are assigned to the component.
The x-axis is each an individual component and the y-axis is the number of components K in the
clustering. The lines between the yellow circles show how related the components are.
The present database contains predominantly studies which target the receptor types serotonin-2A
(5-HT2A, with altanserin, setoperone and 5-I-R91150 radiotracers), dopamine D2 (with FLB 457
and epidepride) and benzodiazepine (with flumazenil and fluoroethylflumazenil). These three types
of experiments group in three separate components.
Results: Brain regions
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Instead of clustering experiments it is also possible
to cluster brain regions. As shown above, this
type will tend to cluster cerebral cortex regions
together.
By examining the centroid from the clustering
of experiments it is possible to determine which
brain regions have the highest values within a
component of clustered experiments, e.g., for the
dopamine studies with the FLB 457 and epidepride
tracers the highest values appear (not surprisingly)
in putamen and caudate nucleus. For the com-
ponent with (5-HT2A) receptor experiments the
regions are anterior cingulate gyrus, parietal, pre-
frontal and occipital cortex.
Summary
Without knowledge of the target under study our
method is able to group molecular neuroimag-
ing studies according to the neuroreceptor under
study.
Our approach is completely automated once the
data has been entered in the database.
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